S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CERE Cerevel Therapeutics Holdings Inc

44.96

0.00 (0.00%)

Feb 27 2025 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

12/05/2023

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

08/04/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Scott Akamine

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Cerevel Therapeutics (NASDAQ:CERE)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Cerevel Therapeutics Charts.

Cerevel Therapeutics (NASDAQ:CERE)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Cerevel Therapeutics Charts.

Cerevel Therapeutics Holdings Inc News

Form 15-12G - Securities registration termination [Section 12(g)]
Monday 12 August 2024 (7 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Monday 5 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 5 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 5 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 5 August 2024 (7 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Monday 5 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 5 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 5 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 5 August 2024 (7 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Thursday 1 August 2024 (7 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Thursday 1 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 1 August 2024 (7 months ago) • Edgar (US Regulatory)

More Cerevel Therapeutics Holdings Inc News Articles

Elite Pharmaceuticals (QB)

Anavex Life Sciences

RespireRx Pharmaceuticals (CE)

Voip Pal Com (QB)

Rennova Health (CE)

Digital Brand Media and ... (PK)

Northwest Biotherapeutics (QB)

Lightwave Logic

Fannie Mae (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions